Autoimmune Disorders Breakout, KI-Mayo Meeting 2023
Program Chairs and Moderators: Eoin Flanagan (MC), Veena Taneja (MC), Lina Diaz (KI), Helena Idborg
Please note that minor change in the agenda might occur.
Autoimmune Disorders Breakout Session
16:00-18:15 PM (Stockholm)/ 9.00-11.15 AM (Rochester)/7:00am (Phoenix)
Welcome and Overview of Session Day One
- 16:00 pm /9:00 am/7:00 am : Welcome to Autoimmune Disorders break out session Day 1
Eoin Flanagan, MC
- 16:10:pm/9:10am/7:10 am: Keynote: Advances in our understanding of the neuroimmunology of multiple sclerosis,
Dr. Fredrik Piehl, KI
- 16:40pm/9:40am/7:40am: Selected abstract 1: “Critical” Demyelinating Lesions Associated with Progressive Multiple Sclerosis;
Dr. B. Mark Keegan, MC
- 16:55pm/9:55am/7:55am: Selected abstract 2: Clinical and Neuroimaging Phenotypes of Autoimmune GFAP Astrocytopathy: A systematic review and meta-analysis, Victor Ineichen, KI
- 17:10pm/10:10am/8:10am: Break
- 17:25pm/10:25am/8:25am:Invited talk: Neurological complications of immune checkpoint inhibitor cancer immunotherapy,
Dr Anastasia Zekeridou, MC
- 17:45pm/10:45am/8:45am:Selected abstract 3: Harnessing Machine Learning to Predict Neuropsychiatric Events in Systemic Lupus Erythematosus,
Dr. Nursen Cetrez, KI
- 18:00pm/11:00am/9:00am: Selected abstract 4: Incidence of Increased Intracranial Pressure in MOGAD,
Dr. Nanthaya Tisavipat, MC
- 19:00pm/12:00am/10:00 am: Murdock Lecture: How does loss of CFTR cause cystic fibrosis lung disease
Michael J. Welsh, M.D., Howard Hughes Medical Institute and University of Iowa
15:00- 19:00 PM (Stockholm); 8:00- 12:00 AM (Rochester) 6:00 -10.00 AM (Phoenix)
Autoimmune Disorders Breakout Session
- 15:00pm/8:00am/6:00am: Welcome to Autoimmune Disorders break out session Day 2
Veena Taneja, MC; Vilija Oke, KI
- 15:10pm/8:10am/6:10am:Keynote: Immunometabolism in Rheumatoid Arthritis,
Dr Cornelia Weyand, MC
- 15:50pm/8:50am/6:50am: Invited talk: Cognitive decline in patients with rheumatoid arthritis: vascular contributions and the role of inflammation
Dr Elena Myasoedova, MC
- 16:10pm/9:10am/7:10am:Selected abstract 5: Multi-omic Phenotyping in Blood For Computational Biomarker Discovery in Rheumatoid Arthritis,
Dr. Jaeyun Sung, MC - 16:25pm/9:25am/7:25am: Selected abstract 6: Impact of Neuropsychiatric Involvement on Health-related Quality of Life in Patients with Systemic Lupus Erythematosus,
Dr. Ioannis Parodis, KI
- 16:40pm/9:40 am/7:40 am: Break
- 16:50/9:50am/7:50am: Invited talk: Single cell sequencing of T cells in Rheumatoid Arthritis and Myositis,
Dr Karine Chemin, KI - 17:15pm/10:15am/8:15am: Selected abstract 7: The Impact of Multimorbidity Burden on Flares and Remission in Patients with Rheumatoid Arthritis,
Dr. Cynthia Crowson, MC
- 17:30pm/10:30am/8:30am: Selected abstract 8: Histopathologic and Clinical Outcomes of Patients with Giant Cell Arteritis and Thoracic Aorta Repair: The Mayo Clinic Experience over Two Decades,
Dr. Mahmut Kaymakci, MC
- 17:45pm/10:45am/8:45am: Selected abstract 9: Evaluation of Cerebrovascular Disease on Autopsy in Patients with Rheumatoid Arthritis,
Dr. Rakesh Kumar. MC
- 18:00pm/11:00am/9:00am: Selected abstract 10: Dementia Case Identification in Rheumatoid Arthritis (RA): Validation of Dementia Diagnostic Codes in a Population-Based RA cohort,
Dr. Roslin Jose George, MC - 19:00pm/12:00am/11:00am: Plenary session